Expression of activated ATF-2, CREB and c-Myc in rat colon transversum after whole-body γ-irradiation and its contribution to pathogenesis and biodosimetry

International Journal of Radiation Biology

Volumn 84, Issue 4, 2008, Pages 315-324

  Pejchal, Jaroslav ^a,b   Österreicher, Jan ^b   Vilasová, Zdeňka ^a   Tichý, Aleš ^b   Vávrová, Jiřina ^b  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

ATF 2; Biodosimetry; c Myc; CREB; Enterocyte; Image analysis

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MYC PROTEIN; SERINE; THREONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DISEASE MODEL; DOSIMETRY; GAMMA IRRADIATION; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INTESTINE CELL; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIATION DOSE; RAT; TIME; TRANSVERSE COLON; WHOLE BODY RADIATION; WISTAR RAT;

ACTIVATING TRANSCRIPTION FACTOR 2; ANIMALS; BIOLOGICAL ASSAY; BODY BURDEN; COLON; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; GAMMA RAYS; GENE EXPRESSION; MALE; RATS; RATS, WISTAR; RELATIVE BIOLOGICAL EFFECTIVENESS; WHOLE-BODY COUNTING; WHOLE-BODY IRRADIATION;

RATTUS; RATTUS NORVEGICUS;

EID: 41749109147     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000801953367     Document Type: Article

References (47)

1. Beier F, Taylor AC, LuValle P. 2000. Activating transcription factor 2 is necessary for maximal activity and serum induction of the cyclin A promoter in chondrocytes. Journal of Biological Chemistry 275:12948-12953.
2. Chen YR, Meyer CF, Tan TH. 1996a. Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis. Journal of Biological Chemistry 271:631-634.
3. Chen YR, Wang X, Templeton D, Davis RJ, Tan TH. 1996b. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. Journal of Biological Chemistry 271:31929-31936.
4. Desdouets C, Matesic G, Molina CA, Foulkes NS, Sassone-Corsi P, Brechot C, Sobczak-Thepot J. 1995. Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM. Molecular and Cellular Biology 15:3301-3309.
5. Dillman JF, McGary KL, Schlager JJ. 2004. An inhibitor of p38 MAP kinase downregulates cytokine release induced by sulfur mustard exposure in human epidermal keratinocytes. Toxicology In Vitro 18:593-599.
6. Driák D, Osterreicher J, Vávrová J, Reháková Z, Vilasová Z. 2007. Morphological changes of rat jejunum after whole body gama-irradiation and their impact in biodosimetry. Physiological Research (in press).
7. Ellington JK, Elhofy A, Bost KL, Hudson MC. 2001. Involvement of mitogen-activated protein kinase pathways in Staphylococcus aureus invasion of normal osteoblasts. Infection and Immunity 69:5235-5242.
8. Fajardo LF. 1982. Pathology of radiation injury. New York: Masson Publishing.
9. Fan S, Ma YX, Wang JA, Yuan RQ, Meng Q, Cao Y, Laterra JJ, Goldberg ID, Rosen EM. 2000. The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3′ kinase. Oncogene 19:2212-2223.
10. Gupta S, Campbell D, Dérijard B, Davis RJ. 1995. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267:389-393.
11. Gupta S, Seth A, Davis RJ. 1993. Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62. Proceedings of the National Academy of Sciences of the USA 90:3216-3220.
12. Hai T, Curran T. 1991. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proceedings of the National Academy of Sciences of the USA 88:3720-3724.
13. Henriksson M, Lüscher B. 1996. Proteins of the Myc network: Essential regulators of cell growth and differentiation. Advances in Cancer Research 68:109-182.
14. Hoang AT, Lutterbach B, Lewis BC, Yano T, Chou TY, Barrett JF, Raffeld M, Hann SR, Dang CV. 1995. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain. Molecular and Cellular Biology 15:4031-4042.
15. Johnson GL, Lapadat R. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911-1912.
16. Kaminska B. 2005. MAPK signalling pathways as molecular targets for anti-inflammatory therapy - from molecular mechanisms to therapeutic benefits. Biochimica et Biophysica Acta 1754:253-262.
17. Kim H, Kokkotou E, Na X, Rhee SH, Moyer MP, Pothoulakis C, Lamont JT. 2005. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase. Gastroenterology 129:1875-1888.
18. Klotz LO, Pellieux C, Briviba K, Pierlot C, Aubry JM, Sies H. 1999. Mitogen-activated protein kinase (p38-, JNK-, ERK-) activation pattern induced by extracellular and intracellular singlet oxygen and UVA. European Journal of Biochemistry 260:917-922.
19. Kool J, Hamdi M, Cornelissen-Steijger P, van der Eb AJ, Terleth C, van Dam H. 2003. Induction of ATF3 by ionizing radiation is mediated via a signaling pathway that includes ATM, Nibrin1, stress-induced MAPkinases and ATF-2. Oncogene 22:4235-4242.
20. Kumar P, Miller AI, Polverini PJ. 2004. p38 MAPK mediates gamma-irradiation-induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway. Journal of Biological Chemistry 279:43352-43360.
21. Lue H, Kapurniotu A, Fingerle-Rowson G, Roger T, Leng L, Thiele M, Calandra T, Bucala R, Bernhagen J. 2006. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Cellular Signalling 18:688-703.
22. Lutterbach B, Hann SR. 1994. Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Molecular and Cellular Biology 14:5510-5522.
23. Ma Q, Li X, Vale-Cruz D, Brown ML, Beier F, LuValle P. 2007. Activating transcription factor 2 controls Bcl-2 promoter activity in growth plate chondrocytes. Journal of Biological Chemistry 101:477-487.
24. Maekawa T, Sakura H, Kanei-Ishii C, Sudo T, Yoshimura T, Fujisawa J, Yoshida M, Ishii S. 1989. Leucine zipper structure of the protein CRE-BP1 binding to the cyclic AMP response element in brain. EMBO Journal 8:2023-2028.
25. Mori T, Wang X, Jung JC, Sumii T, Singhal AB, Fini ME, Dixon CE, Alessandrini A, Lo EH. 2002. Mitogen-activated protein kinase inhibition in traumatic brain injury: in vitro and in vivo effects. Journal of Cerebral Blood Flow and Metabolism 22:444-452.
26. Narang H, Krishna M. 2004. Mitogen-activated protein kinases: Specificity of response to dose of ionizing radiation in liver. Journal of Radiation Research (Tokyo) 45:213-220.
27. Noguchi K, Kitanaka C, Yamana H, Kokubu A, Mochizuki T, Kuchino Y. 1999. Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase. Journal of Biological Chemistry 274:32580-32587.
28. Ouwens DM, de Ruiter ND, van der Zon GC, Carter AP, Schouten J, van der Burgt C, Kooistra K, Bos JL, Maassen JA, van Dam H. 2002. Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38. EMBO Journal 21:3782-3793.
29. Park KM, Chen A, Bonventre JV. 2001. Prevention of kidney ischemia/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. Journal of Biological Chemistry 276:11870-11876.
30. Qi Y, Tu Y, Yang D, Chen Q, Xiao J, Chen Y, Fu J, Xiao X, Zhou Z. 2007. Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression. Journal of Cellular Physiology 210:63-71.
31. Raman M, Earnest S, Zhang K, Zhao Y, Cobb MH. 2007. TAO kinases mediate activation of p38 in response to DNA damage. EMBO Journal 26:2005-2014.
32. Recio JA, Merlino G. 2002. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1. Oncogene 21:1000-1008.
33. Sabbah M, Courilleau D, Mester J, Redeuilh G. 1999. Estrogen induction of the cyclin D1 promoter: Involvement of a cAMP response-like element. Proceedings of the National Academy of Sciences of the USA 96:11217-11222.
34. Sahijdak WM, Yang CR, Zuckerman JS, Meyers M, Boothman DA. 1994. Alterations in transcription factor binding in radioresistant human melanoma cells after ionizing radiation. Radiation Research 138:S47-51.
35. Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR. 2000. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes & Development 14:2501-2514.
36. Shklyaev SS, Namba H, Mitsutake N, Alipov G, Nagayama Y, Maeda S, Ohtsuru A, Tsubouchi H, Yamashita S. 2001. Transient activation of c-Jun NH2-terminal kinase by growth factors influences survival but not apoptosis of human thyrocytes. Thyroid 11:629-636.
37. STANAG 2374: NATO Standardization Agreement No. 2374 (Allied Medical Publication No. 6), NATO Standardization Agency, 2002, pp 120.
38. Suzuki K, Kodama S, Watanabe M. 2006. Low-dose radiation effects and intracellular signaling pathways. Yakugaku Zasshi 126:859-867.
39. Suzuki K, Kodama S, Watanabe M. 2001. Extremely low-dose ionizing radiation causes activation of mitogen-activated protein kinase pathway and enhances proliferation of normal human diploid cells. Cancer Research 61:5396-53401.
40. Teale B, Singh S, Khanna KK, Findik D, Lavin MF. 1992. Purification and characterization of a DNA-binding protein activated by ionizing radiation. Journal of Biological Chemistry 267:10295-10301.
41. Teyssier F, Bay JO, Dionet C, Verrelle P. 1999. Cell cycle regulation after exposure to ionizing radiation. Bulletin du Cancer 86:345-357.
42. Varadkar PA, Krishna M. 2004. Differential activation of kinases in ex vivo and in vivo irradiated mice lymphocytes. Journal of Radiation Research (Tokyo) 45:127-131.
43. Wang X, McGowan CH, Zhao M, He L, Downey JS, Fearns C, Wang Y, Huang S, Han J. 2000. Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Molecular and Cellular Biology 20:4543-4552.
44. Weber NC, Stursberg J, Wirthle NM, Toma O, Schlack W, Preckel B. 2006. Xenon preconditioning differently regulates p44/42 MAPK (ERK 1/2) and p46/54 MAPK (JNK 1/2 and 3) in vivo. British Journal of Anaesthesia 97:298-306.
45. Yacoub A, Park JS, Qiao L, Dent P, Hagan MP. 2001. MAPK dependence of DNA damage repair: Ionizing radiation and the induction of expression of the DNA repair genes XRCC1 and ERCC1 in DU145 human prostate carcinoma cells in a MEK1/2 dependent fashion. International Journal of Radiation Biology 77:1067-1078.
46. Zhang L, Jope RS. 1999. Oxidative stress differentially modulates phosphorylation of ERK, p38 and CREB induced by NGF or EGF in PC12 cells. Neurobiology of Aging 20:271-278.
47. Zingg D, Riesterer O, Fabbro D, Glanzmann C, Bodis S, Pruschy M. 2004. Differential activation of the phosphatidylinositol 3′-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cells. Cancer Research 64:5398-5406.